Supraventricular bradycardia following heart transplantation necessitating pacemaker implantation – An analysis of possible underlying causes

Christof Schmid,Thorsten Wahlers,Michael Jurmann,Jochen Cremer,Hans‐Gerd Fieguth,Hans‐Joachim Schäfers,Axel Haverich

DOI: https://doi.org/10.1111/j.1399-0012.1993.tb00891.x

1993-04-01

Clinical Transplantation

Abstract:Underlying causes for the development of supraventricular bradycardias following heart transplantation are still controversial. A retrospective study investigating preoperative antiarrhythmic drug treatment of the recipient, donor age, ischemic time and surgical complications as possible underlying causes was therefore conducted. From January 1987 through December 1990, 224 orthotopic heart transplantations were performed. After exclusion of redo‐procedures and early deaths, 171 patients (148 male, 23 female; 9 to 62 years, mean 44± 12 yr) were included. While 34 patients showed a supraventricular bradycardia during the early postoperative period (≤14 days), (incidence of 19.9%/Group I), 137 patients demonstrated normal signs rhythm (Group II). All patients in Group I underwent VVI‐pacemaker implantation after a median time interval of 18 d after the initial operation. By Chi‐square‐test analysis, a significant higher cumulative amount of pretransplant antiarrhythmic drug treatment was found in Group I (p< 0.005). However, subsequent multivariant analysis only identified amiodarone to be of significant influence on postoperative pacemaker requirement (ANOVA/Fisher PLSD, 95% confidence level). In contrast, no significant correlation was found with regard to donor age (Group I vs. Group II: 28.1 ± 18.4 yr vs. 26.8± 17.5 yr), ischemic lime (151 ±45 min vs. 149±35 min) and surgical technique. After a follow‐up period of 6 and 12 months, 16 (9.4%) and 15 patients (8.8%) of Group I, respectively, presented ongoing pacemaker demand, whereas 18 and 19 patients, respectively, regained sufficient supraventricular rhythm. In 2 patients surgical reintervention for lead dislocation after endomyocardial biopsy was necessary. It is concluded that about 20% of patients will develop a supraventricular bradycardia after orthotopic heart transplantation that will require a pacemaker. The underlying causes may involve various mechanisms; however, based on our results, only the cumulative amount of preoperative antiarrhythmic drug treatment or amiodarone alone were found to be of significance. Sinoatrial function recovers spontaneously in 50% of the patients within 6 months postoperatively.

surgery,transplantation